NDC product
Migraine Headache Therapy
NDC 17312-041 · TRP Company
Key facts
| Product NDC | 17312-041 |
|---|---|
| Proprietary name | Migraine Headache Therapy |
| Nonproprietary name | ATROPA BELLADONNA - BRYONIA ALBA ROOT - BLACK COHOSH - ARABICA COFFEE BEAN - NITROGLYCERIN - IRIS VERSICOLOR ROOT - SODIUM CHLORIDE - |
| Substances | ATROPA BELLADONNA, BRYONIA ALBA ROOT, BLACK COHOSH, ARABICA COFFEE BEAN, NITROGLYCERIN, IRIS VERSICOLOR ROOT, SODIUM CHLORIDE |
| Dosage form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Labeler | TRP Company |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] and 9 more |
| Marketing start | Apr 1, 2016 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: